05: The Future of Psychedelics in Healthcare
Om avsnittet
Judith Warner speaks with Dr. Matthew Johnson about the state of psychedelic research today and the likelihood that certain drugs — MDMA and psilocybin specifically — could soon be approved for the treatment of conditions like addiction and PTSD. Psychedelics have long been known for their abilities to alter perception, but renewed interest by major research institutions in psychedelics’ ability to treat a range of common disorders has brought some of them to the precipice of FDA approval.
DR. JOHNSON is a professor of Psychiatry and Behavioral Sciences at Johns Hopkins University and a leader in the study of psychedelics for the treatment of addiction.
A transcript of their conversation can be found at Aventine.org/podcast.
The World as You’ll Know It: The Future Of Aging med Aventine finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.